NEW YORK (GenomeWeb) – Rosetta Genomics today announced a nearly 800 percent jump in third quarter revenues from continuing operations as the company benefitted from the sale of products from PersonalizeDx, a molecular diagnostics firm acquired in April.

For the three-month period ended Sept. 30, Rosetta's revenues from continuing operations increased to $2.4 million from $273,000 in the same period last year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.